Cargando…
Medications for attention-deficit/hyperactivity disorder in individuals with or without coexisting autism spectrum disorder: analysis of data from the Swedish prescribed drug register
BACKGROUND: Clinical studies found that medication for attention-deficit/hyperactivity disorder (ADHD) is effective in coexisting autism spectrum disorder (ASD), but current research is based on small clinical studies mainly performed on children or adolescents. We here use register data to examine...
Autores principales: | Johansson, Viktoria, Sandin, Sven, Chang, Zheng, Taylor, Mark J., Lichtenstein, Paul, D’Onofrio, Brian M., Larsson, Henrik, Hellner, Clara, Halldner, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758935/ https://www.ncbi.nlm.nih.gov/pubmed/33357227 http://dx.doi.org/10.1186/s11689-020-09352-z |
Ejemplares similares
-
Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study
por: Chen, Qi, et al.
Publicado: (2014) -
Childhood symptoms of attention‐deficit/hyperactivity disorder and borderline personality disorder
por: Tiger, Annika, et al.
Publicado: (2022) -
Familial co-aggregation of attention-deficit/hyperactivity disorder and autoimmune diseases: a cohort study based on Swedish population-wide registers
por: Hegvik, Tor-Arne, et al.
Publicado: (2021) -
Cardiovascular risk factors in attention‐deficit/hyperactivity disorder: A family design study of Swedish conscripts
por: Garcia‐Argibay, Miguel, et al.
Publicado: (2022) -
Investigating gender-specific effects of familial risk for attention-deficit hyperactivity disorder and other neurodevelopmental disorders in the Swedish population
por: Martin, Joanna, et al.
Publicado: (2020)